We are live on
!
Find out more
Immunic
IMUX
IMUX
20 hedge funds and large institutions have $20.7M invested in Immunic in 2019 Q4 according to their latest regulatory filings, with 2 funds opening new positions, 5 increasing their positions, 5 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
38% more capital invested
Capital invested by funds: $15M → $20.7M (+$5.75M)
0.63% more ownership
Funds ownership: 1.49% → 2.11% (+0.63%)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
0% more repeat investments, than reductions
Existing positions increased: 5 | Existing positions reduced: 5
17% less funds holding
Funds holding: 24 → 20 (-4)
67% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 6
Holders
20
Holders Change
-4
Holders Change %
-16.67%
% of All Funds
0.39%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
2
Increased
5
Reduced
5
Closed
6
Calls
$2.67M
Puts
–
Net Calls
+$2.67M
Net Calls Change
-$103K
Top Buyers
| 1 |
AG
Artal Group
Luxembourg
|
+$5.24M |
| 2 |
Renaissance Technologies
New York
|
+$155K |
| 3 |
BlackRock
New York
|
+$73.3K |
| 4 |
Wells Fargo
San Francisco,
California
|
+$50.1K |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
+$5.74K |
